Table 1.

Selected Characteristics of the Patients According to Pretreatment CA125 Levels.

Pretreatment Serum CA125 Level
<35 U/mL ≥35 U/mL P
No. % No. %
Total 22 100.0 92 100.0
Stage 0.002
  I 11 50.0 17 18.5
  II–IV 11 50.0 75 81.5
Grade 0.01
  1 7 31.8 10 10.9
  2, 3 15 68.2 82 89.1
Gross residual disease present 0.001
  Yes 3 13.6 48 52.2
  No 19 86.4 44 47.8
Platin sensitivity 0.04
  Yes 17 100.0 74 80.4
  No 0 0.0 18 19.6
RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2015 January; 6(1): e0005. ISSN: 2076-9172
Published online 2015 January 29. doi: 10.5041/RMMJ.10180
Copyright: © 2015 Menczer et al.